Recurrent Nerve Monitoring During Aortic Arch Repair
PREMAR
Pilot Study of Recurrent Laryngeal Nerve Monitoring During Neonatal Aortic Arch Repair
1 other identifier
interventional
20
1 country
1
Brief Summary
Almost half of newborns undergoing surgery to repair narrowing or interruption of the aortic arch will suffer injury to the recurrent laryngeal nerve. This causes a weak voice and can lead to problems with feeding including aspiration of milk feed after the surgery. As these children can have a vulnerable circulation, aspiration events can reduce survival and poor weight gain has been shown to correlate with poorer outcomes after surgery. In other types of surgery in the neck, monitors can be used to alert the surgeon to when injury is occurring to the recurrent nerve. To date, this type of monitoring has not been possible in newborns. This study aims to investigate if this type of monitoring is feasible in newborns undergoing aortic arch repair, to prevent recurrent nerve injury.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 11, 2021
CompletedStudy Start
First participant enrolled
March 23, 2021
CompletedFirst Posted
Study publicly available on registry
August 6, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2022
CompletedAugust 6, 2021
April 1, 2021
1.1 years
March 11, 2021
August 5, 2021
Conditions
Outcome Measures
Primary Outcomes (6)
Vocal cord EMG - Burst amplitude (mV)
Feasibility of performing vocal cord EMG during neonatal arch repair
Intra-operative (1 hour)
Vocal cord EMG - Burst duration (ms)
Feasibility of performing vocal cord EMG during neonatal arch repair
Intra-operative (1 hour)
Vocal cord EMG - Burst frequency (Hz)
Feasibility of performing vocal cord EMG during neonatal arch repair
Intra-operative (1 hour)
Vocal cord EMG - Interburst interval (ms)
Feasibility of performing vocal cord EMG during neonatal arch repair
Intra-operative (1 hour)
Vocal cord EMG - Signal to noise ratio (mV)
Feasibility of performing vocal cord EMG during neonatal arch repair
Intra-operative (1 hour)
Correlation of Vocal cord EMG with post-operative palsy
Vocal cord ultrasound
Post extubation / 1 week post-operatively
Secondary Outcomes (1)
Neuromuscular blockade
Intra-operative (1 hour)
Interventions
Needle vocal cord electromyography using Medtronic NIM monitor
Eligibility Criteria
You may qualify if:
- Only patients with parents/ carers able to give informed consent to participation in the trial will be included. • Male and female patients will be included
- Only Neonates (babies less than 28 days of age) will be included in the study.
- Only patients undergoing repair of the aortic arch via median sternotomy will be included in the study
You may not qualify if:
- Patients with severe abnormalities of the airway, such that they are unlikely to be extubated within 7 days of the aortic arch repair surgery will be excluded from participation, as assessment of vocal cord function will be difficult/ impossible in such patients.
- Patients with parents/ carers who are unable to give informed consent to participation in the trial will be excluded from participation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Birmingham Children's Hospital
Birmingham, West Midlands, B4 6NH, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Phil Botha, PhD
Birmingham Women's and Children's Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 11, 2021
First Posted
August 6, 2021
Study Start
March 23, 2021
Primary Completion
May 1, 2022
Study Completion
May 1, 2022
Last Updated
August 6, 2021
Record last verified: 2021-04
Data Sharing
- IPD Sharing
- Will not share